NetEase Inc NTES Files Fiscal 2025 Form 20F Annual Report with Full Stakeholder Access Eli Lilly and Company LLY Announces 23B Planned Acquisition of Ajax Therapeutics to Bolster Hematological Oncology Pipeline How Ambow Edu AMBO cash flow tells the real story Volatility Increases 20260506 What Jack Henry JKHY does that creates lasting value Mini Rally 20260508 Marker Therapeutics Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline LOMA Q1 2026 Earnings Strong EPS Reported Despite Market Headwinds JAGX Q1 2026 Earnings Significant EPS Miss Highlights Operational Challenges REZI Q1 2026 Earnings EPS Beats Estimates Stock Gains 4 VRTS Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly Xtant Medical Holdings Inc XTNT Q1 2026 Earnings EPS Misses Estimates Amidst Narrow Loss